Geovax Labs Inc (GOVX) Q4 2024 Earnings Call Highlights: Strategic Advances Amid Financial ...
Geovax Labs Inc (GOVX) secures a $400 million award for COVID-19 vaccine development while navigating financial hurdles and ...
GeoVax Reports 2024 Year-End Financial Results and Provides Business Update
GEO-CM04S1 BARDA/Project NextGen Phase 2b trial preparations ongoing with manufacturing of clinical trial materials underway ...
EQS-News: GeoVax Labs Announces $4.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
EQS-News: GeoVax, Inc. / Key word (s): Financial GeoVax Labs Announces $4.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules 24.03.2025 / 13:05 CET/CEST The issuer is ...
What's Next: Geovax Labs's Earnings Preview
Analysts anticipate Geovax Labs to report an earnings per share (EPS) of $-0.95. Investors in Geovax Labs are eagerly awaiting the company's announcement, hoping for news of surpassing estimates and ...
Nasdaq2d
GEOVAX LABS Earnings Preview: Recent $GOVX Insider Trading, Hedge Fund Activity, and More
GEOVAX LABS ($GOVX) is expected to release its quarterly earnings data on Thursday, March 27th after market close, per Finnhub. Analysts are expecting revenue of ...
GeoVax Labs, Inc. (NASDAQ:GOVX) Receives $14.20 Consensus Target Price from Brokerages
Shares of GeoVax Labs, Inc. (NASDAQ:GOVX – Get Free Report) have received an average recommendation of “Buy” from the seven ...
The Globe and Mail1mon
GeoVax Anticipates Significant 2025 Progress With Catalyst-Rich Milestones Across Key Programs
ATLANTA, GA - February 5, 2025 (NEWMEDIAWIRE) - GeoVax Labs, Inc. (Nasdaq: GOVX), a clinical-stage biotechnology company developing immunotherapies and vaccines against cancers and infectious ...
Nasdaq1mon
GeoVax Announces Strategic Integration of AI in Support of President Trump's Stargate Initiative
ATLANTA, GA - February 3, 2025 (NEWMEDIAWIRE) - GeoVax Labs, Inc. (Nasdaq: GOVX), a leader in vaccine and immunotherapy development, announced today its endorsement of President Donald J.
GeoVax to Present at the 37th Annual Roth Conference
GeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology company developing immunotherapies and vaccines against cancers and infectious dise ...
Morningstar24d
Geovax Labs Inc GOVX
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
EQS-News: GeoVax Reports 2024 Year-End Financial Results and Provides Business Update
EQS-News: GeoVax, Inc. / Key word (s): Financial GeoVax Reports 2024 Year-End Financial Results and Provides Business Update 27.03.2025 / 21:06 CET/CEST The issuer is solely responsible for the ...
Morningstar25d
Geovax Labs Inc GOVX
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...